diaPASEF-Powered Chemoproteomics Enables Deep Kinome Interaction Profiling
Kathryn WoodsiD, Alexandria M. ChaniD, Thankhoe A. Rants’oiD, Tanmay SapreiD, Grace E. Mastin, Kathleen M. Maguire, Shao‐En OngiD, Martin G. GolkowskiiD
Abstract
Protein-protein interactions (PPIs) underlie most biological functions. Devastating human conditions like cancers, neurological disorders, and infections, hijack PPI networks to initiate disease, and to drive disease progression. Understanding precisely how diseases remodel PPI networks can, therefore, help clarify disease mechanisms and identify therapeutic targets. Protein kinases control most cellular processes through protein phosphorylation. The 518 human kinases, known as the kinome, are frequently dysregulated in disease and highly druggable with ATP-competitive inhibitors. Kinase activity, localization, and substrate recognition are regulated by dynamic PPI networks composed of scaffolding and adapter proteins, other signaling enzymes like small GTPases and E3 ligases, and phospho-substrates. Accordingly, mapping kinase PPI networks can help determine kinome activation states, and, in turn, cellular activation states; this information can be used for studying kinase-mediated cell signaling, and for prioritizing kinases for drug discovery. Previously, we have developed a high-throughput method for kinome PPI mapping based on mass spectrometry (MS)-based chemoproteomics that we named kinobead competition and correlation analysis (kiCCA). Here, we introduce 2nd generation (gen) kiCCA which utilizes data-independent acquisition (dia) with parallel accumulation serial fragmentation (PASEF) MS and a re-designed CCA algorithm with improved selection criteria and the ability to predict multiple kinase interaction partners of the same proteins. Using neuroblastoma cell line models of the noradrenergic-mesenchymal transition (NMT), we demonstrate that 2nd gen kiCCA (1) identified 6.1-times more kinase PPIs in native cell extracts compared to our 1st gen approach, (2) determined kinase-mediated signaling pathways that underly the neuroblastoma NMT, and (3) accurately predicted pharmacological targets for manipulating NMT states. Our 2nd gen kiCCA method is broadly useful for cell signaling research and kinase drug discovery.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- FWCI
- 1.93
- Field percentile
- top 14%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multiplexed profiling of kinase interactomes quantifies cellular network plasticity
M. Golkowski, A. Lius, … S.-E. Ong·bioRxiv·Sep 14, 2021
- Phosphoproteomics-based Profiling of Kinase Activities in Cancer Cells
Jakob Wirbel, Pedro Rodriguez Cutillas, Julio Saez-Rodriguez·bioRxiv·Jul 26, 2016
- High-throughput mapping of kinase-substrate interactions with protein language models and phospho-PCA
Changhua Yu, Edward Pao, David Van Valen·bioRxiv·Oct 28, 2026
- Community detection in empirical kinase networks identifies new members of signaling pathways
Celia De Los Angeles Colomina Basanta, Marya Bazzi, … Pedro R. Cutillas·bioRxiv·Aug 4, 2022
- Kinex infers causal kinases from phosphoproteomics data
Alexandra Valeanu, Verena Golz, … Jitao David Zhang·bioRxiv·Nov 23, 2023
- Chemical proteomics decrypts the kinases that shape the dynamic human phosphoproteome
Florian P Bayer, Julian Müller, … Bernhard Küster·bioRxiv·Nov 18, 2025